BioCentury
ARTICLE | Company News

Myriad Genetics, Novartis Pharmaceuticals Corp. deal

March 16, 1998 8:00 AM UTC

MYGN received a $500,000 milestone from partner Novartis for its discovery of CHD1, a gene associated with cardiovascular disease (see Technology Briefing, BioCentury Part I). ...